C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective

Wilhelm Grander1, Wolfgang Dichtl, Wolfgang Prokop

  • 1Department of Internal Medicine, Division of Cardiology, University Hospital, Leopold-Franzens-University, Innsbruck, Austria. wilhelm.grander@bkh-hall.or.at

Insights

Elevated C-reactive protein (CRP) levels predict restenosis after percutaneous coronary intervention (PCI). Factor VII activity does not correlate with restenosis risk in patients with stable angina.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Biomarkers

Background:

  • Vascular inflammation (C-reactive protein, CRP) and coagulation (factor VII activity, F VII) may predict restenosis after percutaneous coronary intervention (PCI).
  • Stable angina pectoris patients undergoing elective PCI are the focus population.

Purpose of the Study:

  • To investigate the association between baseline CRP levels, F VII activity, and restenosis rate after elective PCI.
  • To evaluate these markers over a 6-month follow-up period.

Main Methods:

  • Prospective study of 81 patients undergoing PCI and 49 controls.
  • CRP and F VII levels measured pre-procedure and 16-24h post-procedure.
  • Clinical restenosis defined as major adverse coronary events (MACE) at 6-month follow-up.

Main Results:

  • Increased CRP levels post-angiography in patients with coronary artery disease.
  • 17 of 81 (21%) patients experienced MACE within 6 months.
  • Higher CRP tertiles independently predicted clinical restenosis (p=0.018).
  • Successful PCI correlated with decreased CRP; MACE patients showed no CRP change.
  • No association found between F VII activity and clinical outcome or changes over time.

Conclusions:

  • Elevated preprocedural and 6-month follow-up CRP plasma levels are associated with clinical restenosis in stable angina patients undergoing PCI.
  • Factor VII plasma activity does not correlate with clinical restenosis after PCI.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...